The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruv Jani

Dhruv Sureshkumar Jani 25 Divine Bunglows, Science City Road, Sola, Ahmedabad - 380060, Gujarat, India Date: August 12, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001, Maharashtra, India Dear Sir / Madam, Sub: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 I undersigned, enclosing herewith a Disclosure regarding Sell of 7,22,000 Equity Shares of Global Longlife Hospital and Research Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The detail of the Target Company is as follow:  Name of the Company: Global Longlife Hospital and Research Limited  BSE Equity Script Code: 543520  ISIN: INE0J2K01014 Please take the same in your record and do the needful. Thanking You, Encl.: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 C.C.: Global Longlife Hospital and Research Limited 703, Sankalp Square, 3B, Beside Taj Skyline, Sindhu Bhavan Road, Ahmedabad - 380059, Gujarat, India Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) Global Longlife Hospital and Research Limited Name(s) of the Seller Dhruv Sureshkumar Jani Whether the Seller belongs to Promoter/Promoter group Yes Name(s) of the Stock Exchange(s) where the shares of TC are BSE Limited Listed Details of the sale of shares as follows Number % w.r.t. total % w.r.t. total diluted share/voting capital share/voting capital of wherever applicable(*) the TC (**) Before the sale of shares, holding of: a) Shares carrying voting rights 7,22,990 6.89 6.89 b) VRs acquired /sold otherwise than by shares - - - c) Voting rights (VR) otherwise than by equity shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying - - - voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 7 ,22,990 6.89 6.89 Details of sale of shares a) Shares carrying voting rights acquired 7,22,000 6.88 6.88 b) VRs acquired otherwise than by equity shares - - - c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying category) - - - acquired d) Shares in the nature of encumbrance (pledge/ lien/ - - - non-disposal undertaking/ others) e) Total (a+b+c+/-d) 7,22,000 6.88 6.88 After the sale of shares, holding of: a) Shares carrying voting rights 990 0.01 0.01 b) VRs otherwise than by equity shares - - - c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying - - - voting rights in the TC (specify holding in each category) after acquisition d) Shares in the nature of encumbrance (pledge/ lien/ - - - non-disposal undertaking/ others) e) Total (a+b+c+d) 990 0.01 0.01 Mode of sale of shares (e.g. open market / public issue / rights Open Market issue / preferential allotment / inter-se transfer/encumbrance, etc.) August 10, 2026 to August 12, 2026 Date of acquisition/ sale of shares / VR or date of receipt of intimation of allotmnet of shares, whichever is applicable Equity share capital / total voting capital of the TC before the Rs. 10,50,00,000/- (1,05,00,000 Equity Shares of Rs. 10/- each) said sale of shares Equity share capital/ total voting capital of the TC after the Rs. 10,50,00,000/- (1,05,00,000 Equity Shares of Rs. 10/- each) said sale of shares Total diluted share/voting capital of the TC after the said sale NA of shares Place: Ahmedabad Date: 12-08-2026 Note: (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.